This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: Jos E Andrés-Gil: Innovator in Pharmaceutical Chemistry
Introduction
Jos E Andrés-Gil is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on substituted tetracyclic azepine derivatives. His research focuses on developing compounds that have potential therapeutic applications.
Latest Patents
Andrés-Gil holds a patent for "Substituted tetracyclic azepine derivatives." This invention concerns compounds of formula (I), which include pharmaceutically acceptable salts and stereoisomeric forms. The compounds have been tested as mCPP-antagonists in rats and may be used as therapeutic agents in the treatment or prevention of CNS disorders, cardiovascular disorders, or gastrointestinal disorders. He has 1 patent to his name.
Career Highlights
Jos E Andrés-Gil is currently associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work at Janssen has allowed him to contribute to the development of innovative therapeutic solutions.
Collaborations
Throughout his career, Andrés-Gil has collaborated with esteemed colleagues, including Victor Karel Sipido and Francisco J Fernández-Gadea. These collaborations have further enriched his research and development efforts.
Conclusion
Jos E Andrés-Gil is a prominent figure in pharmaceutical innovation, with a focus on developing compounds that address critical health issues. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile